Clinical Trials Logo

Ventricular Remodeling clinical trials

View clinical trials related to Ventricular Remodeling.

Filter by:

NCT ID: NCT00132093 Completed - Clinical trials for Myocardial Infarction

Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack

Start date: April 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to ascertain whether treatment with the drug eplerenone, taken early after a heart attack, prevents or reduces some of the adverse changes that may otherwise naturally occur within the heart muscle, that lead ultimately to weakening of the heart muscle and premature death.

NCT ID: NCT00045994 Completed - Hypertension Clinical Trials

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

Start date: August 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of ALT-711 in the treatment of isolated systolic hypertension in a formal study in patients with left ventricular hypertrophy. Eligible patients will be randomized to double-blind treatment once daily for 6 months with oral ALT-711 (210 mg) or placebo.

NCT ID: NCT00038077 Completed - Clinical trials for Heart Failure, Congestive

Reversal of Ventricular Remodeling With Toprol-XL

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease.